menu search

This elite ultra-high-yielding dividend stock adds $3.1 billion in additional fuel to its growth engine

Enterprise Products Partners secured another $3.1 billion in expansion projects. They'll come online in 2025 and boost its cash flow....

November 2, 2023, 9:39 am

Zillow beats 3q expectations but faces uncertain outlook

Zillow (NASDAQ:Z) reported better-than-expected third-quarter earnings, primarily driven by its marketing services for real estate agents, despite a s...

November 2, 2023, 9:37 am

Gbpusd tests key descending trendline

GBPUSD slightly higher today as market digests Fed meeting It tests again the July 14 aggressive descending trendline Momentum indicators remain muted...

November 2, 2023, 9:29 am

Wti oil futures succumb to bearish pressures

WTI futures decline after rejection at 50-day SMA Found their feet around the 80.00 handle, forming potential double bottom Momentum indicators deep i...

November 2, 2023, 9:28 am

Japan pm kishida says will push firms to achieve higher wage hikes next year

Wants to ensure that growth in household income exceeds pace of inflationI reckon it's a consistent theme now across the board that we are going to ex...

November 2, 2023, 9:26 am

Talon metals signs agreement with us doe for $114.8m in bipartisan infrastructure law funding

Talon Metals Corp. (TSX:TLO, OTC:TLOFF) told investors it has signed a definitive agreement with the US Department of Energy (DOE) setting the terms, ...

November 2, 2023, 9:24 am

Lucid diagnostics to present at canaccord genuity medtech, diagnostics, and digital health & services forum

Lishan Aklog, M.D., Chairman & CEO, to Present November 16, 2023, in New York NEW YORK , Nov. 2, 2023 /PRNewswire/ -- Lucid Diagnostics Inc.  (Nasdaq...

November 2, 2023, 9:18 am

In8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting

NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta ...

November 2, 2023, 9:17 am

After a year colt seals the $1.8b purchase of lumen emea

Colt, a service provider for numerous retail brokers, financial firms, and crypto exchanges, announced today (Thursday) that it has acquired Lumen EME...

November 2, 2023, 9:14 am

Sidus space awarded multi-million-dollar contract for commercial lunar transportation

Sidus Space Inc (NASDAQ:SIDU) announced that it has been awarded a five-year Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract, with a $10 mil...

November 2, 2023, 9:13 am

This stock has a 6.05% yield and sells for less than book

the recent Ford share price of $9.91 represents a price-to-book ratio of 0.9 and an annual dividend yield of 6.05%...

November 2, 2023, 9:10 am

Building a sustainable portfolio: 3 esg stocks to buy and hold

At first, the idea of environmental, social and governance or ESG stocks to buy and hold doesn't seem particularly lucrative. Generally, an understand...

November 2, 2023, 9:10 am

Vincerx pharma to present three posters at ash 2023 in december

VIP943 poster supports selectivity and safety of lead CD123 ADC, VIP943, currently in Phase 1 VIP924 poster shows this novel CXCR5-ADC compares favora...

November 2, 2023, 9:10 am

Ferrari again raises guidance as customers opt for high-priced, personalized sports cars

Ferrari raised guidance after its third-quarter profit surged 46% year over year. Its customers continue to load up their new Ferraris with expensive ...

November 2, 2023, 9:09 am

Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato

BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...

November 2, 2023, 9:09 am

Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato

BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...

November 2, 2023, 9:09 am

Baxter international beats q3 profit estimates on strong demand for medical devices

Baxter International on Thursday beat Wall Street expectations for third-quarter revenue and profit, as a recovery in surgical procedure volumes after...

November 2, 2023, 9:08 am

Ecb's knot: policy rates now are at a good 'cruising altitude'

Current level of rates can remain for some timeShould be a little patient and not raise rates too much to prevent choking off the economyIf even the m...

November 2, 2023, 9:08 am

Agios pharmaceuticals to present broad set of clinical and translational data in rare blood disorders at 65th ash annual meeting and exposition

– Both Mitapivat Dose Arms Achieved Statistically Significant Hemoglobin Response in Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease...

November 2, 2023, 9:05 am

7 value stocks to buy while they are still out of the limelight

Although 2023 has witnessed a massive surge in relevant industries – most notably artificial intelligence – investors may want to consider value s...

November 2, 2023, 9:02 am


Search within

Pages Search Results: